RxDoctor Payments DataLook up a doctor →

Rodney Todd, MD

Family Medicine · Roseburg, ORNPI 1629085907

Payments from drug & device makers

$7,821in general payments, 2019–2025

Across 400 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$878
  • Pfizer$677
  • Amgen$503
  • Lilly USA, LLC$461
  • Kowa Pharmaceuticals America, Inc.$378
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$7,792100%
  • Education$280%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,821 in reported general payments places this provider in the 95th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$80,657
Medicare patients
165
Services billed
5,628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban78$97,279
OzempicSemaglutide84$89,054
JardianceEmpagliflozin50$59,239
FarxigaDapagliflozin Propanediol52$58,662
OtezlaApremilast12$58,372
MounjaroTirzepatide24$41,375
XareltoRivaroxaban12$18,711
Spiriva RespimatTiotropium Bromide24$18,677
TrulicityDulaglutide14$16,789
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$13,026
JanumetSitagliptin Phos/Metformin Hcl17$12,502
Semglee (Yfgn) PenInsulin Glargine-Yfgn26$9,377
LivaloPitavastatin Calcium18$8,777
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$8,160
Repatha SyringeEvolocumab11$8,086

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$677$97,27978 claims
Novo NordiskOzempic$337$89,05484 claims
Boehringer IngelheimJardiance, Spiriva Respimat$169$77,91774 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,798$71,68967 claims
AmgenOtezla$503$58,37212 claims
Lilly USA, LLCMounjaro, Trulicity$461$58,16538 claims
Johnson & JohnsonXarelto$83$18,71112 claims
MerckJanumet$55$12,50217 claims
Kowa Pharmaceuticals America, Inc.Livalo$378$8,77718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Roseburg

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →